HuGE Literature Finder
Records 1-5
|
Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Gene 2013 Jul 523 (1): 20-6. Yilmaz-Aydogan Hulya, Kurnaz Ozlem, Kucukhuseyin Ozlem, Akadam-Teker Basak, Kurt Ozlem, Eronat Allison Pinar, Tekeli Atike, Bugra Zehra, Ozturk Og |
|
[Association and interaction of peroxisome proliferator-activated receptor ? with low high-density lipoprotein hyperlipidemia and with peroxisome proliferator-activated receptor ?].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2012 Dec 33 (12): 1218-23. Liu Meng-meng, Gu Shu-jun, Guo Zhi-rong, Wu Ming, Chen Qiu, Zhou Zheng-yuan, Yu Hao, Ding Yi, Luo Wen-s |
|
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI.
Atherosclerosis 2011 Aug 217 (2): 458-64. Peters Bas J M, Pett Helmi, Klungel Olaf H, Stricker Bruno H Ch, Psaty Bruce M, Glazer Nicole L, Wiggins Kerri L, Bis Josh C, de Boer Anthonius, Maitland-van der Zee Anke-Hil |
|
Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial.
Atherosclerosis 2010 Aug 211 (2): 630-7. Solà Rosa, Bruckert Eric, Valls Rosa-Maria, Narejos Silvia, Luque Xavier, Castro-Cabezas Manuel, Doménech Gema, Torres Ferran, Heras Mercedes, Farrés Xavier, Vaquer José-Vicente, Martínez José-Miguel, Almaraz Maria-Cruz, Anguera An |
|
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Pharmacogenomics 2010 Jul 11 (7): 959-71. Ruaño Gualberto, Thompson Paul D, Kane John P, Pullinger Clive R, Windemuth Andreas, Seip Richard L, Kocherla Mohan, Holford Theodore R, Wu Alan H |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: